All products / DC8726
FLLL31
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $600 USDRequest a quote / confirm availability → |
| 250 mg | $1,100 USDRequest a quote / confirm availability → |
| 1 g | $2,200 USDRequest a quote / confirm availability → |
Confirm stock, lead time, shipping and final quotation with our team.
Product overview
FLLL31 selectively binds to Janus kinase 2 and the STAT3 Src homology-2 (SH2) domain, effective inhibitors of STAT3 phosphorylation. STAT3 plays a critical role in early embryogenesis, but is largely dispensable in normal adult cells and tissues. On the other hand the JAK2/STAT3 signaling pathway is persistently activated in great number of human solid and blood cancers. Such activation is commonly associated with a worse prognosis. FLLL31 is a curcumin derivative locked in diketone-tautomeric form, which supposedly improves binding to SH2 domain. The compound inhibits JAK2 kinase activity and prevents STAT3 phosphorylation. FLLK31 is a potent and selective inhibitor of the STAT3 signaling pathway.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC8726 |
|---|---|
| Product name | FLLL31 |
| CAS | 52328-97-9 |
| Molecular formula | C25H28O6 |
| Molecular weight | 424.48622 |
| Purity | >98% |
| SMILES | COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC(C)(C)C)c2C)ccc1O |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — FLLL31 (DC8726)